Qvr LLC Eli Lilly & CO Transaction History

Qvr LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $295,507 - $395,347	499 New	499 $388,000
Q4 2022 Feb 10, 2023	BUY	$321.55 - $374.67 $95,178 - $110,902	296 New	296 $108,000
Q4 2021 Jan 31, 2022	SELL	$224.85 - $279.04 $193,371 - $239,974	-860 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$221.6 - $272.71 $177,280 - $218,167	800 Added 1333.33%	860 $199,000
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $10,833 - $14,012	60 New	60 $14,000

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

Stay updated on Qvr LLC with notifications on news.